跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 14,575 条关于
“62 Capital Pty Ltd”
全部
14,575
临床试验
3,094
药物
1,946
机构
4,381
资讯
5,154
11个月前
Skin Elements Raises $2.5 Million to Commercialize SE Formula Biotechnology Platform
12个月前
LTR Pharma Increases Stake in LevOmega to 43% with $1M Investment for Sustainable Omega-3 Development
9个月前
Australian Court Rules Formulation Patents Ineligible for Patent Term Extensions in Landmark Otsuka Decision
去年
PromarkerEso Blood Test Shows 94% Accuracy in Esophageal Cancer Detection
2年前
BioLineRx's APHEXDA Gains Momentum in Stem Cell Mobilization for Multiple Myeloma
去年
Gilead's Dual-Target CAR-T Therapy Achieves 62% Response Rate in Recurrent Glioblastoma
去年
Kodiak Sciences' KSI-101 Demonstrates 62% Vision Improvement in Phase 1b MESI Trial
9个月前
Microbiota Therapy MaaT013 Achieves 62% Response Rate in Refractory GI-aGVHD Phase 3 Trial
5个月前
MaaT Pharma's Microbiome Therapy Shows 62% Response Rate in Severe Graft-versus-Host Disease
去年
Clinical Trial Media Achieves High Diversity in Alzheimer's and Other Trials Using AI
第 1 页,共 516 页
上一页
下一页